Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromes.
van der Stouwe JG, Godly K, Kraler S, Godly J, Matter CM, Wenzl FA, von Eckardstein A, Räber L, Mach F, Obeid S, Templin C, Lüscher TF, Niederseer D; SPUM‐ACS investigators. van der Stouwe JG, et al. Among authors: kraler s. Eur J Clin Invest. 2024 Dec;54(12):e14314. doi: 10.1111/eci.14314. Epub 2024 Sep 30. Eur J Clin Invest. 2024. PMID: 39350322
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study.
Kraler S, Liberale L, Nopp S, Englisch C, Grilz E, Lapikova-Bryhinska T, Akhmedov A, Carbone F, Ramoni D, Tirandi A, Scuricini A, Isoppo S, Tortorella C, La Rosa F, Michelauz C, Frè F, Gavoci A, Lisa A, Suter TM, von Eckardstein A, Wenzl FA, Pabinger I, Lüscher TF, Montecucco F, Ay C, Moik F. Kraler S, et al. J Thromb Haemost. 2024 Nov;22(11):3125-3136. doi: 10.1016/j.jtha.2024.07.019. Epub 2024 Sep 1. J Thromb Haemost. 2024. PMID: 39223063 Free article.
Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
Wang Y, Zeller M, Auffret V, Georgiopoulos G, Räber L, Roffi M, Templin C, Muller O, Liberale L, Ministrini S, Stamatelopoulos K, Stellos K, Camici GG, Montecucco F, Rickli H, Maza M, Radovanovic D, Cottin Y, Chague F, Niederseer D, Lüscher TF, Kraler S. Wang Y, et al. Among authors: kraler s. Eur Heart J. 2024 Nov 14;45(43):4564-4578. doi: 10.1093/eurheartj/ehae593. Eur Heart J. 2024. PMID: 39217456 Free PMC article.
Proenkephalin Improves Cardio-Renal Risk Prediction in Acute Coronary Syndromes: The KID-ACS Score.
Wenzl FA, Wang P, Arrigo M, Parenica J, Jones DJL, Bruno F, Tarnwski D, Hartmann O, Boucek L, Lang F, Obeid S, Schober A, Kraler S, Akhmedov A, Kahles F, Schober A, Ow KW, Ministrini S, Camici GG, Bergmann A, Liberale L, Jarkovsky J, Schweiger V, Sandhu JK, von Eckardstein A, Templin C, Muller O, Ondrus T, Olic JJ, Roffi M, Räber L, Cao TH, Jungbauer CG, Ng LL, Mebazaa A, Lüscher TF. Wenzl FA, et al. Among authors: kraler s. Eur Heart J. 2024 Aug 31:ehae602. doi: 10.1093/eurheartj/ehae602. Online ahead of print. Eur Heart J. 2024. PMID: 39215600
Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes.
Velagapudi S, Karsai G, Karsai M, Mohammed SA, Montecucco F, Liberale L, Lee H, Carbone F, Adami GF, Yang K, Crucet M, Stein S, Paneni F, Lapikova-Bryhinska T, Jang HD, Kraler S, Vdovenko D, Züllig RA, Camici GG, Kim HS, Laaksonen R, Gerber PA, Hornemann T, Akhmedov A, Lüscher TF. Velagapudi S, et al. Among authors: kraler s. Cardiovasc Res. 2024 Sep 21;120(11):1265-1278. doi: 10.1093/cvr/cvae100. Cardiovasc Res. 2024. PMID: 38739545
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study.
Bruno F, Wenzl FA, De Filippo O, Kraler S, Giacobbe F, Roffi M, Muller O, Räber L, Templin C, De Ferrari GM, D'Ascenzo F, Lüscher TF; SPUM-ACS investigators. Bruno F, et al. Among authors: kraler s. Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):391-402. doi: 10.1093/ehjcvp/pvae024. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38604747
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits.
Preda A, Montecucco F, Carbone F, Camici GG, Lüscher TF, Kraler S, Liberale L. Preda A, et al. Among authors: kraler s. Cardiovasc Res. 2024 Apr 30;120(5):443-460. doi: 10.1093/cvr/cvae047. Cardiovasc Res. 2024. PMID: 38456601 Review.
41 results